HIV Clinical Trials in Frankfurt
2 recruitingFrankfurt, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
HIV Infections
ViiV Healthcare332 enrolled89 locationsNCT06694805
Recruiting
The RESPOND Outcomes Study
HIV
Rigshospitalet, Denmark37,853 enrolled18 locationsNCT04090151